WGS

WGS

NASDAQ

GeneDx Holdings Corp.

34.51

-33.42(-49.2%)
Volume

11.1M

Market Cap

$1.02B

P/E Ratio

-166.38

EPS

$-0.78


Price Chart

Price Alerts

No price alerts set. Add an alert to get notified!

Notify when price goes above $120.00
Notify when price goes above $180.00
Notify when price goes below $180.00

Key Financial Ratios

P/E Ratio

-166.38

P/B Ratio

11.35

EPS

$-0.78

ROE

-6.82%

Profit Margin

-4.92%

Operating Margin

-2.76%

Peer Comparison

Compare TSM with similar companies in the sector

Company Price Change % P/E Market Cap D/E
CRNX
Crinetics Pharmaceuticals, Inc.
$40.75 -1.21% -8.24 $4.27B 0.05
HNGE
Hinge Health, Inc.
$49.75 1.76% -7.67 $3.92B 0.06
IMVT
Immunovant, Inc.
$27.84 -0.04% -10.89 $5.67B 0.00
KYMR
Kymera Therapeutics, Inc.
$82.71 -1.05% -25.61 $6.75B 0.05
NAMS
NewAmsterdam Pharma Company N.V.
$29.85 -0.03% -16.75 $3.43B 0.00
OPCH
Option Care Health, Inc.
$21.30 0.76% 16.18 $3.33B 0.00
OSCR
Oscar Health, Inc.
$17.94 -3.39% -135.68 $4.65B 0.26
PRVA
Privia Health Group, Inc.
$24.29 0.21% 130.56 $3.05B 0.01
TMDX
TransMedics Group, Inc.
$94.93 -2.21% 18.99 $3.28B 1.66
VKTX
Viking Therapeutics, Inc.
$31.31 -1.42% -7.66 $3.63B 0.00

* Peer stocks are selected based on market capitalization and sector

Private Notes

Key Statistics

52 Week High

$170.87

52 Week Low

$32.84

Dividend

$0.00

Dividend Yield

0.00%

About GeneDx Holdings Corp.

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.